HJHannah M. Jacobs

Hannah M. Jacobs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hannah M. Jacobs has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Left Ventricular Diastolic Dysfunction in Youth with Sickle Cell Disease: Evaluating Genotypic Differences and Effects of Hydroxyurea

    by Chukwuemeka Igwe, Isaac Kistler, Christopher Schmitt, Chance Alvarado, Susan Creary, Megan Gunsaulus, Amulya Buddhavarapu, Kan Hor, Hannah Jacobs

    Sickle cell disease (SCD) encompasses a spectrum of genotypes, most commonly Hemoglobin (Hgb)SS and HgbSC. Diastolic dysfunction (DD) is common in SCD and impacts morbidity and mortality. We sought to evaluate if the rates of DD differed by SCD genotype and by hydroxyurea (HU) use among youths. This was a retrospective study of patients with HgbSS and HgbSC who received an echocardiogram, stratifying genotype and HU use. DD was assessed using mitral valve (MV) E/A ratio < 0.8 or > 2, septal E’ < 7 cm/s, lateral E’ 10; and LA: Aortic root (LA: Ao) ratio > 1.3:1. DD was defined as a diastolic aggregate score ≥ 2 of 5. Multivariable regression models adjusted for age were used to estimate the associations of DD with HU use by genotype. 39% of youth with SCD who had an echocardiogram had DD. DD rates were lower in those on HU ( n = 102, 36%) vs. those not on HU ( n = 94, 41%). Adjusting for age, youths with HgbSS on HU had lower odds of DD compared to those not on HU, OR 0.22 [95% CI (0.07, 0.59), p = 0.004]. Conversely, youth with HgbSC on HU had slightly increased odds of DD compared to those not on HU, OR 1.36 [95% CI (0.35, 4.98) p = 0.6]. In contrast to previous studies suggesting HU has no impact in reducing DD over time, our study showed DD was less common among patients with HgbSS on HU. Larger, prospective, multi-center studies are needed to assess longitudinal improvement of DD from baseline for SCD patients on HU.

  • Open Access

    Utility of Follow-Up Surveillance Echocardiograms in Uncomplicated Surgical Closures of Perimembranous Ventricular Septal Defects: A Preliminary Analysis

    by Macala Maney, Carson Richardson, Isaac Kistler, Samantha Fichtner, Hannah Jacobs, Julie B. Aldrich, Clifford L. Cua

    Background: Ventricular septal defects (VSD) are the most common form of congenital heart disease (CHD). Current guidelines recommend surveillance transthoracic echocardiograms (TTE) following surgical closure of perimembranous VSDs (pVSD); however, duration of screening is not explicitly stated. The goal of this study is to determine the utility of follow-up TTEs after uncomplicated pVSD surgical closure. Methods: Single-site retrospective analysis was conducted on patients who underwent pVSD surgical closure. Patients were excluded if diagnosed with other CHD, had complications 1 year post-repair, or lacked data 1 year post-repair. Serial TTEs were reviewed. A Kaplan–Meier curve was used to illustrate the 5-year complication-free survival. Results: A total of 117 patients met inclusion criteria. A 97% 5-year complication-free survival was observed. Four patients had complications >1 year post-repair: one non-obstructive subaortic ridge, one pulmonary vein stenosis, one pinhole residual pVSD, and one ventricular ectopy with ventricular dysfunction. Of the 113 complication-free patients, 197 TTEs were performed with no change in clinical management. Conclusions: Beyond 1 year post-repair, the occurrence of new complications following uncomplicated pVSD surgical closure is rare. Unless clinical concerns arise, the utility of routine TTEs > 1 year post-repair in this uncomplicated post-surgical cohort should be reassessed. Larger multicenter studies are needed to determine the utility of routine TTEs.

  • Open Access

    Cardiac magnetic resonance imaging in the assessment of cardiac injury and toxicity from cancer-related chemotherapy

    by Jason N. Johnson, Tiffany L. Berthod, Xiaoying Cai, M. Jay Campbell, Anudeep K. Dodeja, Chris G. Goode, Kan N. Hor, Hannah M. Jacobs, Simon Lee, Yue-Hin Loke, et al.

    A dedicated guideline to the evaluation of cardiovascular toxicity in pediatric cancer by cardiac magnetic resonance imaging (MRI) does not exist. Therefore, the aim of this document is to provide guidance in the utility, acquisition, and interpretation of cardiac MRI in childhood cancer survivors. We will focus on briefly defining cardiovascular toxicity in childhood cancer survivors and reviewing the key aspects of a detailed cardiac MRI study in a patient with acute versus chronic cardiovascular toxicity. We intend for this document to serve as a guideline on how to perform a cardiac MRI to evaluate cardiac toxicity based on a review of the current literature. There will be a review of a detailed cardiac MRI protocol (bi-ventricular volumes and mass, myocardial strain, tissue characterization, late gadolinium enhancement, and 4 Dimensional/4D flow) in the assessment of cardiovascular toxicity from cancer therapy. It is hoped that the availability of a standardized approach to cardiac MRI assessment in childhood cancer survivors improves cardiovascular care in this population. Graphical Abstract


  • Open Access

    Practice patterns of cardiovascular magnetic resonance use in the diagnosis of pediatric myocarditis: A survey-based study

    by Hannah M. Jacobs, Jonathan H. Soslow, Matthew D. Cornicelli, Shae A. Merves, Ruchira Garg, Mehul D. Patel, Arpit Agarwal, Nilanjana Misra, Michael P. DiLorenzo, M. Jay Campbell, et al.


  • Complications after transesophageal echocardiogram in pediatric patients with gastrostomy tube and/or Nissen fundoplication

    by Hannah M. Jacobs, Julie B. Aldrich, Marc Dutro, Simon Lee, Daniel G. Rowland, Clifford L. Cua

    Introduction Transesophageal echocardiography (TEE) is frequently used in children with and without congenital heart disease when transthoracic echocardiography is inadequate for visualizing cardiac structures. Recent guidelines state relative contraindications of TEE include post-gastrostomy tube (GT) or Nissen fundoplication surgery. No data exist documenting the incidence of complications in this population after a TEE. Aim of this study was to document the incidence of abdominal complications after TEE in pediatric patients who previously had a GT or Nissen fundoplication. Methods Single institution retrospective study was performed evaluating patients from 2013 through 2020. Patients were included if they had previously undergone a GT or Nissen procedure and subsequently underwent a TEE procedure. Baseline demographics were obtained. Major (esophageal/gastric perforation, oropharyngeal dysphagia, GT displacement, and Nissen breakdown) and minor (abdominal pain, feeding intolerance, and GT leakage) complications were recorded. Results Total of 34 patients underwent 48 TEE procedures. Age was 6.2 ± 6.6 years (median 3.0 years, .4 – 23.0 years) and weight was 18.5 ± 14.8 kgs (median 12.4 kgs, 4.2 – 57.5 kg) at time of TEE. Twenty-nine patients had congenital heart disease. Five patients had a Nissen fundoplication, 14 patients had a GT, and 15 patients had both procedures prior to the TEE. No patient had a major abdominal complication after the TEE. One patient had abdominal pain (2.1%), one patient had feeding intolerance and leakage around the GT site (2.1%), and two patients had leakage around the GT site (4.2%) after the TEE. Patients that experienced complications were significantly younger (1.7 ± 1.1 years vs. 6.6 ± 6.7 years, P < .01) and weighed less (8.7 ± 3.5 kg vs. 20.1 ± 15.5 kg, P < .01) than those that had no complications. All minor complications resolved with minimal interventions required. Conclusion In this study, major abdominal complications did not occur after a TEE procedure in pediatric patients that had previous abdominal surgeries. The incidence of minor complications was relatively low and was easily remedied in this patient population. Though a relative contraindication by guidelines, TEE imaging, including transgastric views, can be performed relatively safely in pediatric patients with prior abdominal surgeries if needed.